Production (Stage)
D
Replimune Group, Inc. REPL
$9.37 $0.9411.15% NASDAQ
Recommendation
Prev Close
$8.43
Volume
2,424,856
Avg Vol (90D)
934,912
Market Cap
$649.84M
Dividend & Yield
--
52-Week Range
$4.92 - $17.00
P/E (TTM)
--
EPS (TTM)
-$3.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Video: Thursday's ETF Movers: XBI, URA
5/29/2025 - Market News Video
Replimune to Present at the 2025 Jefferies Global Healthcare Conference
5/29/2025 - Globe Newswire
HC Wainwright Estimates Replimune Group Q3 Earnings
5/27/2025 - MarketBeat
Leerink Partnrs Estimates Replimune Group Q1 Earnings
5/27/2025 - MarketBeat
Replimune Group (NASDAQ:REPL) Shares Gap Up - Here's Why
5/24/2025 - MarketBeat
Traders Buy High Volume of Replimune Group Call Options (NASDAQ:REPL)
5/24/2025 - MarketBeat
Emily Luisa Hill Sells 2,535 Shares of Replimune Group, Inc. (NASDAQ:REPL) Stock
5/24/2025 - Ticker Report
Replimune Group (NASDAQ:REPL) Issues Quarterly Earnings Results
5/24/2025 - Ticker Report
Philip Astley-Sparke Sells 32,279 Shares of Replimune Group, Inc. (NASDAQ:REPL) Stock
5/24/2025 - Ticker Report
Replimune Group's Internal Control Weaknesses Threaten Financial Stability and Investor Confidence
5/24/2025 - TipRanks Financial Blog
Emily Luisa Hill Sells 2,535 Shares of Replimune Group, Inc. (NASDAQ:REPL) Stock
5/23/2025 - MarketBeat
J.P. Morgan Reaffirms Their Buy Rating on Replimune Group (REPL)
5/23/2025 - TipRanks Financial Blog
Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call Transcript
5/23/2025 - Insider Monkey
Replimune Group (REPL, $8.76) Stochastic Oscillator left the overbought zone on May 22, 2025
5/23/2025 - Tickeron - Stocks
Replimune Group files to sell 25.1M shares of common stock for holders
5/23/2025 - The Fly
Point72 Asset Management L.P. Buys Shares of 283,966 Replimune Group, Inc. (NASDAQ:REPL)
5/23/2025 - MarketBeat
Replimune Group Inc (REPL) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
5/23/2025 - GuruFocus
Q4 2025 Replimune Group Inc Earnings Call Transcript
5/23/2025 - GuruFocus
Notable Thursday Option Activity: SMG, REPL, ANF
5/22/2025 - Stock Options Channel
Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript
5/22/2025 - Seeking Alpha: Transcripts
Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
5/22/2025 - Globe Newswire
Replimune Group (REPL, $9.19) entered Uptrend as Momentum indicator ascends above 0 level on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Replimune Group (REPL, $9.19) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Velan Capital Investment Management LP Acquires Shares of 181,367 Replimune Group, Inc. (NASDAQ:REPL)
5/21/2025 - MarketBeat
Soleus Capital Management L.P. Acquires Shares of 262,500 Replimune Group, Inc. (NASDAQ:REPL)
5/21/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$256.36M
EBIT (TTM)
-$259.86M
Net Income (TTM)
-$247.30M
Balance Sheet
Total Assets (Q)
$551.33M
Total Debt (Q)
$76.17M
Total Liabilities (Q)
$135.49M
Book Value Per Share (Q)
$5.39
Cash Flow
Cash from Operations (TTM)
-$192.25M
Cash from Investing (TTM)
-$23.80M
Cash from Financing (TTM)
$252.40M
Net Change in Cash (TTM)
$36.67M
Filings
Filing Date
Thursday, May 22, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
1.33
7-Day Total Return
14.27%
30-Day Total Return
21.53%
60-Day Total Return
-22.05%
90-Day Total Return
-7.59%
Year to Date Total Return
-25.40%
1-Year Total Return
87.03%
2-Year Total Return
-49.46%
3-Year Total Return
-35.51%
5-Year Total Return
-50.11%
52-week Low
May 29, 2024 - $4.92
52-week High
Nov 22, 2024 - $17.00
Valuation
Market Cap
$649.84M - Small Cap
Enterprise Value
$242.20M
Price/Sales (TTM)
--
Price/Book (Q)
1.56
Dividends and Shares
Shares Outstanding
90.92M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.replimune.com
Phone Number
(781) 222-9600
Address
500 Unicorn Park Drive
Woburn, MA 01801
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic... more
NASDAQ 05/29/2025 4:00PM Eastern Quotes delayed